Hypothesis\nAging is driven not only by the accumulation of senescent cells but also by the active release of senescence‑inducing exosomes from immune cells that have adopted a senescent‑like state. These exosomes carry a specific cargo of SASP proteins, miRNAs (e.g., miR‑34a), and iron‑loaded ferritin that reprogram neighboring non‑immune cells into a senescent phenotype, creating a radially expanding wave of tissue dysfunction.\n\n## Mechanistic Basis\nRecent spatial transcriptomics shows senescent‑like microglia limit remyelination through their secretory phenotype [1] and that aged tissues exhibit coordinated epigenomic remodeling of inflammatory pathways [2]. Clonally expanded lymphocytes reside permanently in the CNS [3], suggesting immune cells are long‑lived sources rather than transient responders. Moreover, quasi‑spatial data link senescent mesenchymal cells with immune niches in fibrotic liver [4], and iron dyshomeostasis in aging microglia correlates with senescent phenotypes [5]. Together, these observations imply that immune cells both produce more senescent cells [6] and fail to clear them, but they also broadcast senescence via extracellular vesicles.\n\nWe hypothesize that the exosomal cargo includes:\n- SASP cytokines (IL‑6, CXCL10) that reinforce paracrine senescence,\n- miR‑34a and miR‑146a known to enforce p53/p21 pathways,\n- Ferritin heavy chain loaded with redox‑active iron that catalyzes lipid peroxidation in recipient cells.\n\nThis model explains why senescence markers form gradients radiating from immune clusters: the concentration of immunosuppressive exosomes decays with distance, producing a measurable spatial decay constant.\n\n## Testable Predictions\n1. Exosomes isolated from aged microglia (or CNS‑infiltrating lymphocytes) will induce senescence markers (p16^INK4a, SA‑β‑gal) in young astrocytes or oligodendrocyte precursor cells in vitro.\n2. Pharmacological inhibition of exosome release (e.g., GW4869) in aged mice will flatten the senescence gradient measured by spatial transcriptomics, reducing SASP signal intensity in tissue layers distal to immune clusters.\n3. Loading exosomes with iron chelator or miR‑34a antagomir will attenuate their senescence‑inducing capacity, linking iron homeostasis and miRNA cargo to the pathogenic effect.\n4. Longitudinal imaging of exosome‑tracking dyes in vivo will show a radial spread of fluorescence from immune hotspots that correlates with rising p21 expression over weeks.\n\n## Experimental Design\n- Obtain aged mouse brains (18‑mo) and young controls (3‑mo).\n- Perform immuno‑EM to confirm exosome release from Iba1^+/CD68^+ microglia.\n- Isolate exosomes via ultracentrifugation; characterize cargo by Western blot (IL‑6, ferritin H) and small‑RNA seq.\n- Treat young hippocampal slice cultures with aged‑exosome preparations ± GW4869, iron chelator (deferoxamine), or miR‑34a antagomir.\n- Quantify senescence (p16, SA‑β‑gal) and oxidative stress (4‑HNE) after 48 h.\n- In vivo, administer GW4869 intracerebroventricularly for 4 weeks; then perform Visium spatial transcriptomics to map senescence‑associated gradients relative to immune cell clusters (identified via CD45 immunostaining).\n- Compare gradient slope and intercept between treated and untreated aged mice.\n\nIf exosome‑mediated transmission is central, blocking release or cargo will significantly diminish the spatial spread of senescence, supporting the hypothesis that immune cells are not merely failing janitors but active propagators of the aging program.
